2022
DOI: 10.3390/bios12100870
|View full text |Cite
|
Sign up to set email alerts
|

Application of Microfluidics in Drug Development from Traditional Medicine

Abstract: While there are many clinical drugs for prophylaxis and treatment, the search for those with low or no risk of side effects for the control of infectious and non-infectious diseases is a dilemma that cannot be solved by today’s traditional drug development strategies. The need for new drug development strategies is becoming increasingly important, and the development of new drugs from traditional medicines is the most promising strategy. Many valuable clinical drugs have been developed based on traditional med… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

0
6
0

Year Published

2023
2023
2024
2024

Publication Types

Select...
8
1

Relationship

0
9

Authors

Journals

citations
Cited by 22 publications
(6 citation statements)
references
References 68 publications
0
6
0
Order By: Relevance
“…Microfluidic systems have been shown to increase analysis speed and efficiency by automating the analysis process, reducing the consumption of samples or reagents (microfluidic systems typically work with microliter quantities of reagents) [ 43 ]. They can also be used to reduce human intervention in experiments [ 44 ], reduce experiment pollution [ 45 ], and allow for the efficient repeating of experiments through multiplexing [ 46 ]. Fluids in these microliter quantities have different behaviors compared to fluids on a macroscale; for example, they have low Reynolds or Grashof numbers.…”
Section: Point-of-care (Poct) Assays For Infectious Diseasesmentioning
confidence: 99%
“…Microfluidic systems have been shown to increase analysis speed and efficiency by automating the analysis process, reducing the consumption of samples or reagents (microfluidic systems typically work with microliter quantities of reagents) [ 43 ]. They can also be used to reduce human intervention in experiments [ 44 ], reduce experiment pollution [ 45 ], and allow for the efficient repeating of experiments through multiplexing [ 46 ]. Fluids in these microliter quantities have different behaviors compared to fluids on a macroscale; for example, they have low Reynolds or Grashof numbers.…”
Section: Point-of-care (Poct) Assays For Infectious Diseasesmentioning
confidence: 99%
“…Moreover, droplet microfluidics is widely used in biomedical research due to their simple and easy operation and high-throughput encapsulation capability. For example, droplet microfluidics has been used in drug encapsulation ( Li et al, 2022 ; Chen et al, 2023 ), targeted drug delivery ( Jia et al, 2022 ; Sartipzadeh et al, 2022 ), and multi-functionalization of carriers ( Wu et al, 2010 ).…”
Section: Droplet Generation and Single-cell Encapsulationmentioning
confidence: 99%
“…In another application, droplet-based microfluidics have been widely adopted for the synthesis of drug-loaded microcapsules for drug delivery, including site targeting and controlled release, in tumor therapy and pharmacological research [ 139 , 140 , 141 ]. Delivery is an important aspect of drug development.…”
Section: Droplet-based Microfluidic Technology For Pharmaceutical App...mentioning
confidence: 99%